Cedrus LLC Merck & Co., Inc. Transaction History
Cedrus LLC
- $200 Billion
- Q2 2024
A detailed history of Cedrus LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cedrus LLC holds 2,901 shares of MRK stock, worth $336,080. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,901
Previous 2,554
13.59%
Holding current value
$336,080
Previous $337 Million
6.57%
% of portfolio
0.18%
Previous 0.18%
Shares
11 transactions
Others Institutions Holding MRK
# of Institutions
3,828Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$28.3 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$24 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.6 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.4 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.61 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $293B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...